Browsing Category
Asahi Kasei
AsahiKASEI Europe launches new website!
AsahiKASEI is pleased to announce the launch of our brand new website!
We provide an easy way to learn about our CEOLUS™ products, services and solutions. Asahi Kasei is a leading manufacturer and supplier of functional excipients for pharmaceutical and nutraceutical industries, located in Japan.…
Read More...
Read More...
A Quality by Design (QbD) study in direct compression using the most flowable microcrystalline…
OBJECTIVE
CEOLUSTM UF-702 is the most flowable microcrystalline cellulose (MCC). While UF-702 has higher compactibility than standard grade PH-102, it has the lowest repose angle of known commercial grades of MCC. This is because the UF-702 particle has a round shape and has many pores inside its…
Read More...
Read More...
Prevention of tablet weight loss and tablet surface abrasion on tablet coating using highly…
OBJECTIVE
When large-size tablets are coated, there are often problems of tablet surface abrasion and tablet weight loss due to coating. For these formulations, CEOLUSTM KG-1000, an extremely highly compactible MCC is an effective tool to increase tablet hardness and improve friability, preventing…
Read More...
Read More...
The CEOLUS™ UF Difference Disintegration and Dissolution Profiles
Optimizing a product's disintegration and dissolution profile is a priority in the formulation development of pharmaceuticals. Read on to discover what makes CEOLUS™ different and why you can trust us to take your products to the next level.
CEOLUS™ by Asahi Kasei
CEOLUS™, high-performance MCC…
Read More...
Read More...
CEOLUS™ – Innovative Tableting Solutions by Asahi Kasei
Asahi Kasei's pharmaceutical excipients CEOLUS™ offers a wide range of solutions to many problems facing the industry, including:
Significant Tablet Size Reduction
The high compactibility of Ceolus™ UF-711 allows for sufficient hardness from a smaller amount of MCC used, thus enabling tablet size…
Read More...
Read More...
Development and evaluation of nano-formulations for immediate release oral dosage forms of poorly…
Inaugural-Dissertation to obtain the academic degree Doctor rerum naturalium (Dr. rer. nat.) submitted to the Department of Biology, Chemistry, Pharmacy of Freie Universität Berlin by Zun Huang
Solubility and dissolution rate are essential for the oral absorption and thus bioavailability of…
Read More...
Read More...
Asahi Kasei Contributes to Global Health Care by Supporting Increased Demand for Ceolus™…
NEW YORK--(BUSINESS WIRE)--Forecast expectations for increased global market demand in the excipients industry were confirmed at CPhI this past November where Asahi Kasei, a diversified Japanese multinational company, was met with warm reception for Ceolus™, their ultra-compactible and…
Read More...
Read More...
Hyaluronic Acid Nanogel as a Protein Delivery System
Purpose
Hyaluronic acid (HA) nanogel has hyaluronic acid in the main chain, a hydrophilic, biocompatible material with low toxicity, and a hydrophobic group in the side chain. A nanoordered gel is spontaneously formed, due to its hydrophilic-hydrophobic interactions, in which it is possible to load…
Read More...
Read More...
Characterization of Tableting Speed-Dependent Deformation Properties of Active Pharmaceutical…
A quantitative evaluation method for determining the effect of tableting speed on the compression properties of pharmaceutical powders was investigated in this study. Cilostazol and ibuprofen were used as active pharmaceutical ingredients (APIs) and mixed with lactose monohydrate and…
Read More...
Read More...
Impressions of the Excipients Hall at CPhI 2021
Today is the last day of the CPhI worldwide in Milan 2021. We want to show you the general look and feel with a few walkthroughs and photos.Walkthrough Excipients Hall 7 at CPhI 2021 in Milan
:Walkthrough Hall P-Mec at CPhI 2021 in Milan:
See our interview with beneo at the CPhI 2021…
Read More...
Read More...